Skip to main content

BIOS Fund I, LP's Form 4 filing

Lantern Pharma Inc. (LTRN) · filed May 29, 2025

Accession no.
0001104659-25-054422
Filed
May 29, 2025, 9:55 PM ET
Trade date
May 27-29, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 15 non-derivative transactions and 0 derivative transactions. Open-market sales total $168.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
BIOS Fund I, LPCIK 000169731610% Owner
BIOS Fund I QP, LPCIK 000170029710% Owner
BIOS Fund II, LPCIK 000171457610% Owner
BIOS Fund II QP, LPCIK 000171686910% Owner
BIOS Fund II NT, LPCIK 000172885110% Owner
Fletcher Aaron G.L.CIK 000178949010% Owner
Bios Equity Partners II, LPCIK 000181331310% Owner
Bios Equity Partners, LPCIK 000181331410% Owner
BIOS Advisors GP, LLCCIK 000181384410% Owner
BIOS Capital Management, LPCIK 000181384510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 27, 2025Common StockSSaleDisposed−3,790$3.05−$11,559.5213,763IndirectDuplicate filing
May 28, 2025Common StockSSaleDisposed−2,702$2.87−$7,754.74211,061IndirectDuplicate filing
May 29, 2025Common StockSSaleDisposed−3,639$3.03−$11,026.17207,422IndirectDuplicate filing
May 27, 2025Common StockSSaleDisposed−6,479$3.05−$19,760.95365,471IndirectDuplicate filing
May 28, 2025Common StockSSaleDisposed−4,620$2.87−$13,259.4360,851IndirectDuplicate filing
May 29, 2025Common StockSSaleDisposed−6,221$3.03−$18,849.63354,630IndirectDuplicate filing
May 27, 2025Common StockSSaleDisposed−1,000$3.05−$3,05056,467IndirectDuplicate filing
May 28, 2025Common StockSSaleDisposed−714$2.87−$2,049.1855,753IndirectDuplicate filing
May 29, 2025Common StockSSaleDisposed−961$3.03−$2,911.8354,792IndirectDuplicate filing
May 27, 2025Common StockSSaleDisposed−7,478$3.05−$22,807.9421,808IndirectDuplicate filing
May 28, 2025Common StockSSaleDisposed−5,332$2.87−$15,302.84416,476IndirectDuplicate filing
May 29, 2025Common StockSSaleDisposed−7,180$3.03−$21,755.4409,296IndirectDuplicate filing
May 27, 2025Common StockSSaleDisposed−2,290$3.05−$6,984.5129,163IndirectDuplicate filing
May 28, 2025Common StockSSaleDisposed−1,632$2.87−$4,683.84127,531IndirectDuplicate filing
May 29, 2025Common StockSSaleDisposed−2,199$3.03−$6,662.97125,332IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)